Added benefit of linagliptin is not proven

Linagliptin is approved to improve blood glucose control in adults with type 2 diabetes mellitus. As the drug manufacturer chose a different appropriate comparator therapy than specified by the Federal Joint Committee, no proof of an added benefit of linagliptin can be inferred from the manufacturer's dossier. Read more